Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

The evanescence and persistence of RBC alloantibodies in blood donors.

Hauser RG, Esserman D, Karafin MS, Tan S, Balbuena-Merle R, Spencer BR, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Gottschall JL, Hendrickson JE, Tormey CA; (for the NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III)).

Transfusion. 2020 Apr;60(4):831-839. doi: 10.1111/trf.15718. Epub 2020 Feb 15.

PMID:
32061102
2.

Antenatal blood transfusion in South Africa: indications and practice in a high-HIV-prevalence setting.

Bloch EM, Hull J, Green-Thompson R, Ingram C, Crookes RL, Fawcus S, Anthony J, Courtney L, Roubinian N, Jauregui A, Hilton JF, Murphy EL; NHLBI REDS-III South Africa Program.

Transfusion. 2020 Mar;60(3):479-487. doi: 10.1111/trf.15661. Epub 2020 Jan 7.

PMID:
31909499
3.

Equivalent inpatient mortality among direct-acting oral anticoagulant and warfarin users presenting with major hemorrhage.

Bialkowski W, Tan S, Mast AE, Kiss JE, Kor D, Gottschall J, Wu Y, Roubinian N, Triulzi D, Kleinman S, Choi Y, Brambilla D, Zimrin A; NHLBI Recipient Epidemiology and Donor Evaluation (REDS)-III Study.

Thromb Res. 2020 Jan;185:109-118. doi: 10.1016/j.thromres.2019.11.024. Epub 2019 Nov 25.

PMID:
31794885
4.

Association of donor age, body mass index, hemoglobin, and smoking status with in-hospital mortality and length of stay among red blood cell-transfused recipients.

Roubinian NH, Westlake M, St Lezin EM, Edgren G, Brambilla DJ, Lee C, Bruhn R, Cable RG, Triulzi DJ, Glynn SA, Kleinman S, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Transfusion. 2019 Nov;59(11):3362-3370. doi: 10.1111/trf.15541. Epub 2019 Oct 11.

5.

Transfusion-Associated Circulatory Overload and Transfusion-Related Acute Lung Injury: Etiology and Prevention.

Roubinian NH, Triulzi DJ.

Hematol Oncol Clin North Am. 2019 Oct;33(5):767-779. doi: 10.1016/j.hoc.2019.05.003. Epub 2019 Jul 30. Review.

PMID:
31466603
6.

Blood donor component-recipient linkages: is there fire where there is smoke?

Roubinian NH, Kanias T.

Transfusion. 2019 Aug;59(8):2485-2488. doi: 10.1111/trf.15450. No abstract available.

PMID:
31374151
7.

Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion.

Roubinian NH, Plimier C, Woo JP, Lee C, Bruhn R, Liu VX, Escobar GJ, Kleinman SH, Triulzi DJ, Murphy EL, Busch MP.

Blood. 2019 Sep 26;134(13):1003-1013. doi: 10.1182/blood.2019000773. Epub 2019 Jul 26.

8.

The impact of recipient factors on the lower-than-expected hemoglobin increment in transfused outpatients with hematologic diseases.

Karafin MS, Bruhn R, Roubinian NH, Chowdhury D, Qu L, Snyder EL, Murphy EL, Brambilla D, Cable RG, Hilton JF, St Lezin E; NHLBI Recipient Epidemiology and Donor Evaluation (REDS)-III Study.

Transfusion. 2019 Aug;59(8):2544-2550. doi: 10.1111/trf.15439. Epub 2019 Jul 4.

PMID:
31270827
9.

Red blood cell transfusions for emergency department patients with gastrointestinal bleeding within an integrated health system.

Mark DG, Huang J, Plimier C, Reed ME, Escobar GJ, Vinson DR, Roubinian NH.

Am J Emerg Med. 2019 Jun 10. pii: S0735-6757(19)30396-1. doi: 10.1016/j.ajem.2019.06.019. [Epub ahead of print]

PMID:
31208843
10.

Association of Blood Donor Sex and Prior Pregnancy With Mortality Among Red Blood Cell Transfusion Recipients.

Edgren G, Murphy EL, Brambilla DJ, Westlake M, Rostgaard K, Lee C, Cable RG, Triulzi D, Bruhn R, St Lezin EM, Erikstrup C, Ullum H, Glynn SA, Kleinman S, Hjalgrim H, Roubinian NH; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) Group.

JAMA. 2019 Jun 11;321(22):2183-2192. doi: 10.1001/jama.2019.7084.

11.

Building consensus: steps toward standardised haemovigilance reporting.

Roubinian N, Kleinman S.

Lancet Haematol. 2019 Jul;6(7):e339-e340. doi: 10.1016/S2352-3026(19)30081-X. Epub 2019 May 9. No abstract available.

PMID:
31080133
12.

Discovery of False Elite Controllers: HIV Antibody-Positive RNA-Negative Blood Donors Found To Be on Antiretroviral Therapy.

Sykes W, Van den Berg K, Jacobs G, Jauregui A, Roubinian N, Wiesner L, Maartens G, Swanevelder R, Custer B, Busch M, Jentsch U, Murphy EL, Vermeulen M; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

J Infect Dis. 2019 Jul 19;220(4):643-647. doi: 10.1093/infdis/jiz145.

13.

Influence of blood storage age on immune and coagulation parameters in critically ill transfused patients.

Norris PJ, Schechtman K, Inglis HC, Adelman A, Heitman JW, Vilardi R, Shah A, Roubinian NH, Danesh A, Guiltinan AM, Keating SM, Lacroix J, Cohen MJ, Spinella PC.

Transfusion. 2019 Apr;59(4):1223-1232. doi: 10.1111/trf.15250. Epub 2019 Mar 18.

14.

TACO and TRALI: biology, risk factors, and prevention strategies.

Roubinian N.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):585-594. doi: 10.1182/asheducation-2018.1.585. Epub 2018 Dec 14. Review.

15.

Long-Term Outcomes Among Patients Discharged From the Hospital With Moderate Anemia: A Retrospective Cohort Study.

Roubinian NH, Murphy EL, Mark DG, Triulzi DJ, Carson JL, Lee C, Kipnis P, Kleinman S, Liu VX, Escobar GJ.

Ann Intern Med. 2019 Jan 15;170(2):81-89. doi: 10.7326/M17-3253. Epub 2018 Dec 18.

16.

Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Karafin MS, Tan S, Tormey CA, Spencer BR, Hauser RG, Norris PJ, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Gottschall JL, Hendrickson JE.

Transfusion. 2019 Jan;59(1):217-225. doi: 10.1111/trf.15004. Epub 2018 Nov 14.

PMID:
30427537
17.

Clinical trials evaluating red blood cell transfusion thresholds: An updated systematic review and with additional focus on patients with cardiovascular disease.

Carson JL, Stanworth SJ, Alexander JH, Roubinian N, Fergusson DA, Triulzi DJ, Goodman SG, Rao SV, Doree C, Hebert PC.

Am Heart J. 2018 Jun;200:96-101. doi: 10.1016/j.ahj.2018.04.007. Epub 2018 Apr 7.

PMID:
29898855
18.

Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.

Karafin MS, Westlake M, Hauser RG, Tormey CA, Norris PJ, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Hendrickson JE; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Br J Haematol. 2018 Jun;181(5):672-681. doi: 10.1111/bjh.15182. Epub 2018 Apr 19.

19.

Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory Overload.

Roubinian NH, Hendrickson JE, Triulzi DJ, Gottschall JL, Michalkiewicz M, Chowdhury D, Kor DJ, Looney MR, Matthay MA, Kleinman SH, Brambilla D, Murphy EL; National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Crit Care Med. 2018 Apr;46(4):577-585. doi: 10.1097/CCM.0000000000002948.

20.

A multicentre study investigating vital sign changes occurring in complicated and uncomplicated transfusions.

Gehrie EA, Roubinian NH, Chowdhury D, Brambilla DJ, Murphy EL, Gottschall JL, Wu Y, Ness PM, Strauss RG, Hendrickson JE; NHLBI Recipient Epidemiology-Donor Evaluation Study (REDS-III).

Vox Sang. 2018 Feb;113(2):160-169. doi: 10.1111/vox.12621. Epub 2017 Dec 25.

21.

Demographic and epidemiologic characterization of transfusion recipients from four US regions: evidence from the REDS-III recipient database.

Karafin MS, Bruhn R, Westlake M, Sullivan MT, Bialkowski W, Edgren G, Roubinian NH, Hauser RG, Kor DJ, Fleischmann D, Gottschall JL, Murphy EL, Triulzi DJ; National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Transfusion. 2017 Dec;57(12):2903-2913. doi: 10.1111/trf.14370. Epub 2017 Oct 24.

22.

Differentiating pulmonary transfusion reactions using recipient and transfusion factors.

Roubinian NH, Looney MR, Keating S, Kor DJ, Lowell CA, Gajic O, Hubmayr R, Gropper M, Koenigsberg M, Wilson GA, A Matthay M, Toy P, Murphy EL; TRALI Study Group.

Transfusion. 2017 Jul;57(7):1684-1690. doi: 10.1111/trf.14118. Epub 2017 May 3.

23.

Statistical Caution in Big Data Approaches to Transfusion Medicine Research.

Roubinian N, Brambilla D, Murphy EL.

JAMA Intern Med. 2017 Jun 1;177(6):860-861. doi: 10.1001/jamainternmed.2017.0914. No abstract available.

PMID:
28437522
24.

Adjusting the Focus on Transfusion-associated Circulatory Overload.

Roubinian N, Murphy EL.

Anesthesiology. 2017 Mar;126(3):363-365. doi: 10.1097/ALN.0000000000001507. No abstract available.

PMID:
28072600
25.

Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm.

Roubinian NH, Hendrickson JE, Triulzi DJ, Gottschall JL, Chowdhury D, Kor DJ, Looney MR, Matthay MA, Kleinman SH, Brambilla D, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Vox Sang. 2017 Jan;112(1):56-63. doi: 10.1111/vox.12466. Epub 2016 Dec 21.

26.

Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.

Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC.

Cochrane Database Syst Rev. 2016 Oct 12;10:CD002042. Review.

27.

Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication.

Hendrickson JE, Roubinian NH, Chowdhury D, Brambilla D, Murphy EL, Wu Y, Ness PM, Gehrie EA, Snyder EL, George Hauser R, Gottschall JL, Kleinman S, Kakaiya R, Strauss RG; National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Transfusion. 2016 Oct;56(10):2587-2596. doi: 10.1111/trf.13730. Epub 2016 Jul 26.

28.

Red Blood Cell Transfusion Strategies in Adult and Pediatric Patients with Malignancy.

Roubinian N, Carson JL.

Hematol Oncol Clin North Am. 2016 Jun;30(3):529-40. doi: 10.1016/j.hoc.2016.01.001. Epub 2016 Feb 18. Review.

PMID:
27112994
29.

2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium.

Spitalnik SL, Triulzi D, Devine DV, Dzik WH, Eder AF, Gernsheimer T, Josephson CD, Kor DJ, Luban NL, Roubinian NH, Mondoro T, Welniak LA, Zou S, Glynn S; State of the Science in Transfusion Medicine Working Groups.

Transfusion. 2015 Sep;55(9):2282-90. doi: 10.1111/trf.13250. Epub 2015 Aug 10.

30.

Restrictive red blood cell transfusion strategies appear safe in most clinical settings.

Roubinian NH, Carson JL.

Evid Based Med. 2015 Oct;20(5):170. doi: 10.1136/ebmed-2015-110218. Epub 2015 Jul 28. No abstract available.

PMID:
26220955
31.

Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions.

Roubinian NH, Looney MR, Kor DJ, Lowell CA, Gajic O, Hubmayr RD, Gropper MA, Koenigsberg M, Wilson GA, Matthay MA, Toy P, Murphy EL; TRALI Study Group.

Transfusion. 2015 Aug;55(8):1838-46. doi: 10.1111/trf.13021. Epub 2015 Feb 23.

32.

Shedding a little light on posttransfusion purpura.

Roubinian NH, Leavitt AD.

Transfusion. 2015 Feb;55(2):232-4. doi: 10.1111/trf.12934. No abstract available.

PMID:
25683186
33.

A multicenter study of plasma use in the United States.

Triulzi D, Gottschall J, Murphy E, Wu Y, Ness P, Kor D, Roubinian N, Fleischmann D, Chowdhury D, Brambilla D; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Transfusion. 2015 Jun;55(6):1313-9; quiz 1312. doi: 10.1111/trf.12970. Epub 2014 Dec 19.

34.

Trends in red blood cell transfusion and 30-day mortality among hospitalized patients.

Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Transfusion. 2014 Oct;54(10 Pt 2):2678-86. doi: 10.1111/trf.12825. Epub 2014 Aug 18.

35.

Decreased red blood cell use and mortality in hospitalized patients.

Roubinian NH, Escobar GJ, Liu V, Gardner MN, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

JAMA Intern Med. 2014 Aug;174(8):1405-7. doi: 10.1001/jamainternmed.2014.2889. No abstract available.

36.

Predicting red blood cell transfusion in hospitalized patients: role of hemoglobin level, comorbidities, and illness severity.

Roubinian NH, Murphy EL, Swain BE, Gardner MN, Liu V, Escobar GJ; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III); Northern California Kaiser Permanente DOR Systems Research Initiative.

BMC Health Serv Res. 2014 May 10;14:213. doi: 10.1186/1472-6963-14-213.

37.

Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*.

Looney MR, Roubinian N, Gajic O, Gropper MA, Hubmayr RD, Lowell CA, Bacchetti P, Wilson G, Koenigsberg M, Lee DC, Wu P, Grimes B, Norris PJ, Murphy EL, Gandhi MJ, Winters JL, Mair DC, Schuller RM, Hirschler NV, Rosen RS, Matthay MA, Toy P; Transfusion-Related Acute Lung Injury Study Group.

Crit Care Med. 2014 Jul;42(7):1676-87. doi: 10.1097/CCM.0000000000000323.

38.

Response.

Roubinian N, Blanc PD, Chen H.

Chest. 2013 Mar;143(3):877. doi: 10.1378/chest.12-2898. No abstract available.

39.

Effects of commercial air travel on patients with pulmonary hypertension air travel and pulmonary hypertension.

Roubinian N, Elliott CG, Barnett CF, Blanc PD, Chen J, De Marco T, Chen H.

Chest. 2012 Oct;142(4):885-892. doi: 10.1378/chest.11-2016.

40.

Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis.

Wiita AP, Roubinian N, Khan Y, Chin-Hong PV, Singer JP, Golden JA, Miller S.

Transpl Infect Dis. 2012 Jun;14(3):248-58. doi: 10.1111/j.1399-3062.2012.00723.x. Epub 2012 Mar 5.

PMID:
22385394
41.

A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America.

Greninger AL, Chen EC, Sittler T, Scheinerman A, Roubinian N, Yu G, Kim E, Pillai DR, Guyard C, Mazzulli T, Isa P, Arias CF, Hackett J, Schochetman G, Miller S, Tang P, Chiu CY.

PLoS One. 2010 Oct 18;5(10):e13381. doi: 10.1371/journal.pone.0013381.

42.

Treatment-related risk factors for hospital mortality in Candida bloodstream infections.

Labelle AJ, Micek ST, Roubinian N, Kollef MH.

Crit Care Med. 2008 Nov;36(11):2967-72. doi: 10.1097/CCM.0b013e31818b3477.

PMID:
18824910
43.

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.

Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH.

Antimicrob Agents Chemother. 2007 Oct;51(10):3568-73. Epub 2007 Aug 6.

44.

Before-after study of a standardized hospital order set for the management of septic shock.

Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, Murphy T, Prentice D, Ruoff BE, Kollef MH.

Crit Care Med. 2006 Nov;34(11):2707-13.

PMID:
16943733
45.

Neisseria meningitidis endotoxin and capsule transmission by transplantation.

Roubinian N, Kirkpatrick BD, Lynn F, Zenilman J, Bash M.

Emerg Infect Dis. 2005 Aug;11(8):1326-7. No abstract available.

Supplemental Content

Loading ...
Support Center